← All Topics / ade

FDA ADE reports for lotilaner (isoxazoline ectoparasiticide (flea/tick)) — total reports, species & reaction breakdown

ade_lotilaner_adverse_events

ade 214 tok en 2026-07-21

lotilaner — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-21. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. lotilaner is a isoxazoline ectoparasiticide (flea/tick).

Total reports

lotilaner: 13432

Reports by species (top entries)

  • Dog 11534
  • Cat 859
  • Human 27
  • Cattle 1
  • Pig 1

Top reported reactions (VEDDRA terms, top entries)

  • Vomiting 3355
  • Diarrhoea 1586
  • UNPALATABLE 906
  • Other abnormal test result NOS 848
  • Lack of efficacy (ectoparasite) - tick NOS 759
  • Seizure NOS 729
  • Lack of efficacy (bacteria) - Borrelia 707
  • Lethargy (see also Central nervous system depression in Neurological) 676
  • Lethargy (see also Central nervous system depression in 'Neurological') 667
  • Lack of efficacy (ectoparasite) - flea 637

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-21.json (openFDA animalandveterinary/event.json, pulled 2026-07-21).

Sources

  • openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-21